WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 52
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 62

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 4'551  4'506  4'460  4'414  4'368  3'858  3'398  3'147 
Births 62  62  63  63  63  56  57  51 
Surviving infants 62  62  62  63  63  55  57  50 
Pop. less than 5 years 315  318  321  319  312  283  277  257 
Pop. less than 15 years 916  911  907  902  895  877  790  856 
Female 15-49 years 1'087  1'086  1'086  1'085  1'084  991  900  772 

Number of reported case

(Click for retrospective incidence data for New Zealand)
Diphtheria 20 
Japanese encephalitis
Measles 280  68  597  43  65 
Mumps 18  23  26  52  14  50 
Pertussis 1'099  3'396  5'598  1'992  462  4'143  91 
Polio*
Rubella 22  26 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)**
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for New Zealand)
Vaccine year result method % card seen                                                
BCG          20 
DTP1          93  93  94  95  95  89 
DTP3          93  92  93  95  93  90  90  76 
DTP4          84 
IPV1          93 
HepB_BD          89 
HepB3          93  93  93  95  90  90 
Hib3          93  92  93  94  89  90 
JapEnc         
MCV1          93  92  92  93  91  85  90  80 
MCV2          86  86  85  86 
PCV1          93  94  93  94  90 
PCV3          93  93  92  92  89 
Pol3          93  92  93  95  93  82 
Rota1         
Rota_last         
Rubella1          93  92  93 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for New Zealand)
DTP1 93  93  94  95  95  96  96  91 
DTP3 93  92  93  95  93  90  90  76 
HepB3 93  93  93  95  90  90 
HepB_BD
Hib3 93  92  93  94  89  90 
MCV1 93  92  92  93  91  85  90  80 
MCV2 86  86  85  86 
PCV3 93  93  92  92  89 
Pol3 93  92  93  95  93  82  90 
Rota_last

Number of districts in the country 20  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 0
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes For infants at increased risk of tuberculosis
DTaPHibHepIPV 6 weeks; 3, 5 months; Yes and other eligible individuals
DTaPIPV 4 years; Yes and other eligible individuals
HPV 12 years (x3); Yes and other eligible individuals
HepA Yes for eligible individuals
HepB Yes eligible individuals
Hib 15 months; Yes and other eligible individuals
IPV Yes eligible individuals
Influenza_Adult Yes Adults with chronic diseases, pregnant women, health care workers, Haj and travelers and other risk groups
Influenza_Pediatric Yes At risk children
MMR 15 months; 4 years; Yes and other eligible individuals
MenACWY Yes eligible individuals
MenC_conj Yes From July 2014
Pneumo_conj 6 weeks; 3, 5, 15 months; Yes and other eligible individuals
Pneumo_ps Yes high risk children and pre and post splenectomy
Rotavirus 6 weeks; 3, 5 months; Yes
Td 45, 65 years; Yes also for some risk groups
Tdap 11 years; Yes pregnant woman between gestational weeks 28 and 38 during epidemics
Varicella Yes eligible individuals

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes   
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number 20  20  20         

System performance

Total Nº districts in country number 20  20  20  20  20     
Nº districts with DTP3 coverage >=80% number  
% of districts with DTP3 coverage >=80% From 0 to 100%    
Nº districts with measles (MCV1) coverage >=95% number              
% of districts with MCV1 coverage >=95% From 0 to 100%            

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes   

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 100  100  100  100  100  100   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.